PostEra
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $26M
Investors
- 9
About PostEra
Based in Massachusetts, US, and founded in 2019 by its CEO, Aaron Morris, CTO Matt Robinson, and CSO Alpha Lee, PostEra Inc. is a biotechnology company that uses machine learning for preclinical drug discovery. In January 2022, PostEra Inc. PostEra Inc. offers medicinal chemistry powered by machine learning and reduces their clients' cycle times. The company has developed COVID oral antiviral candidates via the COVID Moonshot, the advancement of several drug discovery efforts with biopharma partners, and the launch of Manifold as an industry synthesis platform. PostEra Inc.
Who invested in PostEra
9 investors across 2 rounds
See all investors in PostEra
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PostEra
Who invested in PostEra?
PostEra has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PostEra raised?
PostEra has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PostEra last raise money?
PostEra's most recent round on record is a Series A, in Dec 2021.
What does PostEra do?
Based in Massachusetts, US, and founded in 2019 by its CEO, Aaron Morris, CTO Matt Robinson, and CSO Alpha Lee, PostEra Inc.
Where is PostEra headquartered?
PostEra is headquartered in Boston, US.
Which VCs invest in companies like PostEra?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at PostEra's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like PostEra? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.